Eisai And Arena Pharmaceuticals Get FDA Approval For BELVIQ XR Extended-Release Tablets

By: via Benzinga
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) and Eisai Inc. revealed that the Food and Drug Administration has approved its New Drug ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.